China approves first self-developed COVID-19 vaccine

Published : Thursday, 31 December, 2020 at 12:06 PM Count : 885

Observer Online Desk

China announced on Thursday that it had granted conditional marketing authorization for its first self-developed COVID-19 vaccine.

The inactivated vaccine, which got the approval from the National Medical Products Administration (NMPA), is developed by the Beijing Biological Products Institute Co., Ltd. under the China National Biotec Group (CNBG), which is affiliated with Sinopharm, reports Xinhua.

The interim results of its phase-3 clinical trials show 79.34 percent efficacy against COVID-19, meeting the standards of the World Health Organization and the NMPA, according to a press conference by the State Council joint prevention and control mechanism against COVID-19.

Also read

How cities around the world will bid farewell to 2020

Man called most prolific serial killer in US history dies

28 killed in Syria bus attack

26 killed in Aden airport attack after arrival of new Yemen govt

California nurse tests positive a week after receiving vaccine

Turkish court gives 92 life sentences in 2016 coup trial

Switzerland reports first death after Pfizer COVID-19 vaccine shot

Israel spy Jonathan Pollard flies to Tel Aviv

Editor : Iqbal Sobhan Chowdhury

Published by the Editor on behalf of the Observer Ltd. from Globe Printers, 24/A, New Eskaton Road, Ramna, Dhaka.
Editorial, News and Commercial Offices : Aziz Bhaban (2nd floor), 93, Motijheel C/A, Dhaka-1000.
Phone: PABX- 41053001-06; Online: 41053014; Advertisement: 41053012.
E-mail: district@dailyobserverbd.com, news@dailyobserverbd.com, advertisement@dailyobserverbd.com, For Online Edition: mailobserverbd@gmail.com

🔝